- Home
- CPBI vs ICCM Comparison
CPBI vs ICCM Comparison
Compare CPBI & ICCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | CPBI | ICCM |
|---|---|---|
| Founded | 2023 | 2006 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.8M | 45.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CPBI | ICCM |
|---|---|---|
| Price | $16.45 | $0.67 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.50 |
| AVG Volume (30 Days) | 4.8K | ★ 375.3K |
| Earning Date | 01-01-0001 | 11-19-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 7.32 | N/A |
| EPS | ★ 0.96 | N/A |
| Revenue | ★ $19,961,000.00 | $2,975,000.00 |
| Revenue This Year | N/A | $13.67 |
| Revenue Next Year | N/A | $38.55 |
| P/E Ratio | $17.14 | ★ N/A |
| Revenue Growth | ★ 9.30 | N/A |
| 52 Week Low | $13.00 | $0.59 |
| 52 Week High | $16.71 | $1.66 |
Technical Indicators
Market Signals| Indicator | CPBI | ICCM |
|---|---|---|
| Relative Strength Index (RSI) | 63.24 | 39.01 |
| Support Level | $16.26 | $0.67 |
| Resistance Level | $16.55 | $0.72 |
| Average True Range (ATR) | 0.09 | 0.03 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 85.29 | 5.66 |
Price Performance
Historical ComparisonAbout CPBI Central Plains Bancshares Inc.
Central Plains Bancshares Inc operates as the bank holding company for Home Federal Savings and Loan Association of Grand Island that provides mortgage, consumer, commercial real estate, and commercial loans, The bank business consists mainly of accepting deposits from the general public and investing those deposits, together with funds generated from operations, in one- to four-family residential mortgage loans secured by properties located in primary market area, as well as commercial real estate loans.
About ICCM IceCure Medical Ltd.
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.